Published in Arch Ophthalmol on March 01, 1993
Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol (1997) 0.77
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci U S A (1995) 5.66
Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A (1999) 4.05
Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med (1996) 2.46
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest (1996) 2.36
Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care (1994) 2.30
Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci (2000) 2.05
Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol (2000) 2.03
Ocular pathology in congenital heart disease. Eye (Lond) (2005) 1.96
Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. Am J Ophthalmol (1997) 1.92
Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. Diabetes Metab Rev (1997) 1.86
Lightning-induced ocular injury. Arch Ophthalmol (1995) 1.81
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care (1999) 1.78
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes (1999) 1.76
Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome. N Engl J Med (1987) 1.76
Dominant inheritance of optic pits. Am J Ophthalmol (1997) 1.74
A comparative histologic study of the fibrillin microfibrillar system in the lens capsule of normal subjects and subjects with Marfan syndrome. Invest Ophthalmol Vis Sci (1998) 1.71
Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem (2000) 1.67
Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology (2001) 1.65
Perforating ocular fishhook injury. Arch Ophthalmol (1992) 1.54
A third locus (GLC1D) for adult-onset primary open-angle glaucoma maps to the 8q23 region. Am J Ophthalmol (1998) 1.50
Immunohistochemical localization of fibrillin in human ocular tissues. Relevance to the Marfan syndrome. Arch Ophthalmol (1995) 1.44
Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol (1993) 1.38
Hypoxia induces vascular endothelial growth factor gene and protein expression in cultured rat islet cells. Diabetes (1998) 1.38
Comparison of clinical characteristics of familial and sporadic acquired accommodative esotropia. J AAPOS (2001) 1.36
Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes (1995) 1.35
Possible contribution of hyalocytes to idiopathic epiretinal membrane formation and its contraction. Br J Ophthalmol (2009) 1.31
Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study. Ophthalmology (2007) 1.25
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest (1995) 1.24
Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display. FASEB J (1994) 1.20
Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. Ophthalmology (1991) 1.18
Update on the molecular genetics of retinitis pigmentosa. Ophthalmic Genet (2001) 1.17
Angiogenesis and ophthalmic disease. Angiogenesis (1999) 1.15
The natural history of Leber's congenital amaurosis. Age-related findings in 35 patients. Ophthalmology (1992) 1.10
Oral erythromycin treatment for childhood blepharokeratitis. J AAPOS (2000) 1.10
Glaucoma in the Marfan syndrome. Trans Am Ophthalmol Soc (1992) 1.09
Ophthalmologic manifestations of X-linked childhood adrenoleukodystrophy. Ophthalmology (1987) 1.09
Horizontal gaze palsy with progressive scoliosis can result from compound heterozygous mutations in ROBO3. J Med Genet (2006) 1.08
Ocular malformations, moyamoya disease, and midline cranial defects: a distinct syndrome. Am J Ophthalmol (1999) 1.07
Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis. Gut (1991) 1.07
Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci (1996) 1.06
Basic fibroblast growth factor induces expression of VEGF receptor KDR through a protein kinase C and p44/p42 mitogen-activated protein kinase-dependent pathway. Diabetes (1999) 1.03
An Arg311Gln NR2E3 mutation in a family with classic Goldmann-Favre syndrome. Br J Ophthalmol (2005) 1.03
Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J Biol Chem (1998) 1.03
Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes (1996) 1.02
Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci (1996) 1.02
A family with the Bardet-Biedl syndrome and diabetes mellitus. Arch Ophthalmol (1989) 0.98
A specific increased expression of insulin receptor substrate 2 in pancreatic beta-cell lines is involved in mediating serum-stimulated beta-cell growth. Diabetes (1998) 0.96
Bilateral melanosis of the iris. Am J Ophthalmol (1987) 0.96
Neovascular glaucoma and ischemia. J Clin Neuroophthalmol (1986) 0.96
Optic nerve head swelling and optic atrophy in the systemic mucopolysaccharidoses. Ophthalmology (1990) 0.96
APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis. Gut (1997) 0.95
Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes (1998) 0.95
A histopathologic study of the pigmented fundus lesions in familial adenomatous polyposis. Retina (1992) 0.93
The ocular findings in Kniest dysplasia. Am J Ophthalmol (1985) 0.93
Waardenburg's recessive anophthalmia syndrome. Ophthalmic Paediatr Genet (1984) 0.92
Aniridia, atypical iris defects, optic pit and the morning glory disc anomaly in a family. Ophthalmic Paediatr Genet (1986) 0.91
Periocular pigmentation in the Peutz-Jeghers syndrome. Am J Ophthalmol (1986) 0.91
Mapping a new genetic locus for X linked retinitis pigmentosa to Xq28. J Med Genet (2006) 0.89
A new locus for dominant drusen and macular degeneration maps to chromosome 6q14. Am J Ophthalmol (2000) 0.87
Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth. Invest Ophthalmol Vis Sci (2000) 0.86
Dipeptide metalloendoprotease substrates are glucose transport inhibitors and membrane structure perturbants. Biochemistry (1986) 0.86
A family with a syndrome of ectopia lentis, spontaneous filtering blebs, and craniofacial dysmorphism. Ophthalmic Genet (1995) 0.86
von Willebrand factor and retinal circulation in early-stage retinopathy of type 1 diabetes. Diabetes Care (2000) 0.86
Hepatoblastoma, pigmented ocular fundus lesions and jaw lesions in Gardner syndrome. Am J Med Genet (1988) 0.86
Confirmation of the autosomal recessive syndrome of ectopia lentis and distinctive craniofacial appearance. Am J Med Genet (2001) 0.85
Screening relatives of patients with familial chronic open angle glaucoma. Ophthalmology (2000) 0.85
Vascular endothelial growth factor and the eye. Past, present and future. Arch Ophthalmol (1996) 0.84
Clinical spectrum of chromosome 6-linked autosomal dominant drusen and macular degeneration. Am J Ophthalmol (2000) 0.84
Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition. Diabet Med (2001) 0.84
Melanocytoma of the ciliary body: presentation of four cases and review of nineteen reports. Surv Ophthalmol (1985) 0.84
Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. J Clin Invest (2000) 0.84
Crystalline retinopathy. Ann Ophthalmol (1987) 0.84
Microcephaly, colobomatous microphthalmia, short stature, and severe psychomotor retardation in two male cousins: a new MCA/MR syndrome? Am J Med Genet (1999) 0.83
Keeping in touch with angiogenesis. Nat Med (2000) 0.83
Keratoconus after penetrating keratoplasty. Ophthalmic Surg (1990) 0.83
Visual outcome after surgery for Peters' anomaly. Ophthalmic Genet (1994) 0.82
Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest (1995) 0.82
Progression of retinopathy in olivopontocerebellar atrophy with retinal degeneration. Arch Ophthalmol (1992) 0.82
Extraocular muscle aplasia in Moebius syndrome. J Pediatr Ophthalmol Strabismus (1986) 0.81
Dominant radial drusen and Arg345Trp EFEMP1 mutation. Am J Ophthalmol (2001) 0.81
Vascular endothelial growth factor expression in canine peripheral vein bypass grafts. J Vasc Surg (1997) 0.81
Angiogenic factors in diabetic ocular disease: mechanisms of today, therapies for tomorrow. Int Ophthalmol Clin (1998) 0.80
Bilateral microphthalmia with cyst, facial clefts, and limb anomalies: a new syndrome with features of Waardenburg syndrome, cerebro-oculo-nasal syndrome, and craniotelencephalic dysplasia. Am J Med Genet A (2003) 0.80
The genetics of strabismus. Am Orthopt J (2001) 0.80
Canthaxanthine retinopathy. Arch Ophthalmol (1999) 0.79
Retinal pigment epithelium tear as a cause of vitreous hemorrhage. Ann Ophthalmol (1985) 0.79
The retinopathy of primary hyperoxaluria. Retina (1985) 0.79
Anterior segment malformations in 18q- (de Grouchy) syndrome. Ophthalmic Paediatr Genet (1993) 0.79
Duane's retraction syndrome in the fetal alcohol syndrome. Am J Ophthalmol (1990) 0.79
Spondylometaphyseal dysplasia with cone-rod dystrophy. Ophthalmic Genet (2010) 0.78
Strabismus in the Marfan syndrome. Am J Ophthalmol (1994) 0.78
Isolation of genes differentially expressed at the downstream anastomosis of prosthetic arterial grafts with use of mRNA differential display. J Vasc Surg (1995) 0.77
Familial posterior lenticonus and microcornea. Arch Ophthalmol (1992) 0.77
Regression activity that is naturally present in vitreous becomes ineffective as patients develop proliferative diabetic retinopathy. Diabetologia (2013) 0.76
Corneal opacities in Gaucher disease. Am J Ophthalmol (1998) 0.76
Familial adenomatous polyposis. Dis Colon Rectum (1989) 0.76
Dominant syndrome with isolated cryptophthalmos and ocular anomalies. Am J Med Genet (1992) 0.76
Hereditary pigmented paravenous chorioretinal atrophy. Arch Ophthalmol (1986) 0.76
Ocular findings in partial trisomy 3q. A case report and review of the literature. Ophthalmic Paediatr Genet (1988) 0.76